[Ropivacaine infiltration during breast cancer surgery: postoperative acute and chronic pain effect].
Decrease acute pain after breast cancer surgery by an infiltration of ropivacaine. Analyse effect on chronic pain. Prospective randomised double blind versus placebo study. Eighty-one patients randomised between two groups received wound infiltration with 40 ml of ropivacaine 4.75 mg/ml or placebo. Acute pain was assessed during 24h with analogical visual scale and antalgic consumption. One year later, telephonic interviews looked for chronic pain and evaluate it with McGill Pain Questionnaire. Analogical visual scale pain score, antalgic consumption and chronic pain incidence were similar between groups. Ropivacaine scar infiltration provided no acute or chronic pain relief after breast cancer surgery.